Bank of America’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
SAM
KCM
FCM
RI
MBAM
Bank of America's XGN Position: Q1 2026 in Review
Bank of America sold out of Exagen (XGN) in Q1 2026, closing a stake of 17,601 shares — an estimated $107K sold.
Bank of America first reported a position in XGN in Q4 2019 and held it in 25 quarters. The position peaked at $611K in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.
- Bank of America reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 17,601 Exagen shares in Q1 2026, an estimated $107K.
- Bank of America first reported a position in Exagen in Q4 2019 and held it in 25 quarters.
- Bank of America's Exagen position peaked at $611K in Q3 2025.
- 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.